SeaBridge Investment Advisors LLC Lowers Stake in Healthpeak Properties, Inc. (NYSE:DOC)

SeaBridge Investment Advisors LLC trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 63.7% in the 4th quarter, HoldingsChannel reports. The firm owned 40,575 shares of the real estate investment trust’s stock after selling 71,192 shares during the period. SeaBridge Investment Advisors LLC’s holdings in Healthpeak Properties were worth $822,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Healthpeak Properties in the 2nd quarter valued at $66,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Healthpeak Properties in the second quarter valued at $9,024,000. Centaurus Financial Inc. acquired a new stake in Healthpeak Properties in the second quarter valued at $227,000. Massmutual Trust Co. FSB ADV purchased a new stake in Healthpeak Properties during the 3rd quarter worth about $108,000. Finally, AMF Tjanstepension AB acquired a new position in shares of Healthpeak Properties during the 3rd quarter worth about $15,548,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 0.7 %

Shares of DOC stock opened at $20.66 on Friday. The business’s fifty day moving average price is $20.75 and its 200 day moving average price is $21.55. The firm has a market capitalization of $14.45 billion, a PE ratio of 43.96, a P/E/G ratio of 2.18 and a beta of 1.14. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. Healthpeak Properties, Inc. has a 1-year low of $16.01 and a 1-year high of $23.26.

Analyst Ratings Changes

DOC has been the subject of several recent analyst reports. Mizuho decreased their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Wells Fargo & Company reduced their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Robert W. Baird increased their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and boosted their price target for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Finally, Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research report on Wednesday, January 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $24.15.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.